CVM
Price
$9.06
Change
+$0.12 (+1.34%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
46.93M
TECH
Price
$49.87
Change
-$4.77 (-8.73%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
7.82B
89 days until earnings call
Interact to see
Advertisement

CVM vs TECH

Header iconCVM vs TECH Comparison
Open Charts CVM vs TECHBanner chart's image
Cel-Sci
Price$9.06
Change+$0.12 (+1.34%)
Volume$2.61K
Capitalization46.93M
Bio-Techne
Price$49.87
Change-$4.77 (-8.73%)
Volume$244.68K
Capitalization7.82B
CVM vs TECH Comparison Chart in %
Loading...
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.34B. The market cap for tickers in the group ranges from 58 to 210.97B. NONOF holds the highest valuation in this group at 210.97B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was -1%. For the same Industry, the average monthly price growth was 12%, and the average quarterly price growth was 13%. JWCTF experienced the highest price growth at 164%, while RGBPP experienced the biggest fall at -45%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -7%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was 129%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 84
Price Growth Rating: 56
SMR Rating: 93
Profit Risk Rating: 95
Seasonality Score: -13 (-100 ... +100)

Notable companies

The most notable companies in this group are Cel-Sci Corp (ASE:CVM).

Market Cap

The average market capitalization across the group is 3.93B. The market cap for tickers in the group ranges from 46.93M to 7.82B. TECH holds the highest valuation in this group at 7.82B. The lowest valued company is CVM at 46.93M.

High and low price notable news

The average weekly price growth across all stocks in the group was -4%. For the same group, the average monthly price growth was 148%, and the average quarterly price growth was -25%. CVM experienced the highest price growth at 7%, while TECH experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the group was 81%. For the same stocks of the group, the average monthly volume growth was 112% and the average quarterly volume growth was 862%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 32
Price Growth Rating: 47
SMR Rating: 90
Profit Risk Rating: 100
Seasonality Score: -12 (-100 ... +100)
VS
CVM vs. TECH commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVM is a StrongBuy and TECH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (CVM: $9.14 vs. TECH: $49.87)
Brand notoriety: CVM: Notable vs. TECH: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVM: 22% vs. TECH: 301%
Market capitalization -- CVM: $46.93M vs. TECH: $7.82B
CVM [@Biotechnology] is valued at $46.93M. TECH’s [@Biotechnology] market capitalization is $7.82B. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVM’s FA Score shows that 0 FA rating(s) are green whileTECH’s FA Score has 2 green FA rating(s).

  • CVM’s FA Score: 0 green, 5 red.
  • TECH’s FA Score: 2 green, 3 red.
According to our system of comparison, TECH is a better buy in the long-term than CVM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVM’s TA Score shows that 5 TA indicator(s) are bullish while TECH’s TA Score has 3 bullish TA indicator(s).

  • CVM’s TA Score: 5 bullish, 4 bearish.
  • TECH’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CVM is a better buy in the short-term than TECH.

Price Growth

CVM (@Biotechnology) experienced а +6.53% price change this week, while TECH (@Biotechnology) price change was -13.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.54%. For the same industry, the average monthly price growth was +12.42%, and the average quarterly price growth was +13.42%.

Reported Earning Dates

CVM is expected to report earnings on May 15, 2025.

TECH is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (-0.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECH($7.82B) has a higher market cap than CVM($46.9M). CVM YTD gains are higher at: -23.814 vs. TECH (-30.569). TECH has higher annual earnings (EBITDA): 283M vs. CVM (-21.96M). TECH has more cash in the bank: 141M vs. CVM (1.92M). CVM has less debt than TECH: CVM (10.5M) vs TECH (423M). TECH has higher revenues than CVM: TECH (1.21B) vs CVM (0).
CVMTECHCVM / TECH
Capitalization46.9M7.82B1%
EBITDA-21.96M283M-8%
Gain YTD-23.814-30.56978%
P/E RatioN/A108.41-
Revenue01.21B-
Total Cash1.92M141M1%
Total Debt10.5M423M2%
FUNDAMENTALS RATINGS
CVM vs TECH: Fundamental Ratings
CVM
TECH
OUTLOOK RATING
1..100
355
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10080
PRICE GROWTH RATING
1..100
3560
P/E GROWTH RATING
1..100
5212
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECH's Valuation (4) in the Biotechnology industry is significantly better than the same rating for CVM (98). This means that TECH’s stock grew significantly faster than CVM’s over the last 12 months.

TECH's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CVM (100). This means that TECH’s stock grew similarly to CVM’s over the last 12 months.

TECH's SMR Rating (80) in the Biotechnology industry is in the same range as CVM (100). This means that TECH’s stock grew similarly to CVM’s over the last 12 months.

CVM's Price Growth Rating (35) in the Biotechnology industry is in the same range as TECH (60). This means that CVM’s stock grew similarly to TECH’s over the last 12 months.

TECH's P/E Growth Rating (12) in the Biotechnology industry is somewhat better than the same rating for CVM (52). This means that TECH’s stock grew somewhat faster than CVM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CVMTECH
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
64%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
59%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
69%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 13 days ago
71%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
71%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
74%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CICFX63.810.36
+0.57%
American Funds Invmt Co of Amer 529F
UOPIX127.19N/A
N/A
ProFunds UltraNASDAQ-100 Inv
EIFGX30.72N/A
N/A
Eaton Vance Focused Growth Opps I
GCTRX49.46N/A
N/A
Goldman Sachs US Tax-Managed Eq R6
GCCHX20.38-0.27
-1.31%
GMO Climate Change III

CVM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CVM has been loosely correlated with NRXS. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CVM jumps, then NRXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVM
1D Price
Change %
CVM100%
+2.24%
NRXS - CVM
58%
Loosely correlated
-1.19%
MDGL - CVM
43%
Loosely correlated
-0.24%
CYTK - CVM
40%
Loosely correlated
-2.82%
ADXN - CVM
39%
Loosely correlated
+0.22%
EYPT - CVM
38%
Loosely correlated
-2.85%
More

TECH and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TECH has been loosely correlated with AXON. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if TECH jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECH
1D Price
Change %
TECH100%
-8.73%
AXON - TECH
61%
Loosely correlated
-0.40%
SYRE - TECH
48%
Loosely correlated
-5.39%
ADPT - TECH
47%
Loosely correlated
+5.79%
IDYA - TECH
45%
Loosely correlated
-2.03%
CDXS - TECH
45%
Loosely correlated
-2.39%
More